United Kingdom Alternative Protein Market Size & Outlook, 2025-2033
United Kingdom Alternative Protein Market Insights
- According to Deep Market Insights analysis, the United Kingdom Alternative Protein Market size was USD 1718.92 Million in 2024 and is projected to reach USD 4682.25 Million by 2033.
- The United Kingdom market is projected to grow at a CAGR of 11.91% between 2026 and 2033.
- By segment, Plant Based Protein emerged as the largest Protein Source in terms of market size in 2024.
- Cell Based Protein is anticipated to remain the most attractive Protein Source segment, recording the fastest growth during the forecast period.
![United Kingdom Alternative Protein Market Size, Share & Growth Report By [2033]](https://deepmarketinsights.com/uploads/charts/united-kingdom-alternative-protein-market-united-kingdom-protein-source-241194.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United Kingdom contributed 4.66% to the global Alternative Protein Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Alternative Protein Market.
- In Europe, Germany is projected to capture the leading share of market size by 2033.
- Among Europe markets, France is expected to post the fastest growth, reaching USD 3628.28 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 1718.92 Million |
| Market Size In 2033 | USD 4682.25 Million |
| Largest segment | Plant Based Protein |
| Units | Revenue in USD Million |
| CAGR | 11.91% (2025-2033) |
| Segmnetation Covered | |
| Protein Source |
|
| Application Area |
|
| Product Form |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Alternative Protein Market Protein Source 2025-2033 (USD Million)
| Protein Source | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Plant Based Protein | XX.x | XX.x | XX.x | 915.32 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fermentation Derived Protein | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cell Based Protein | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Alternative Protein Market Application Area 2025-2033 (USD Million)
| Application Area | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meat Alternatives | XX.x | XX.x | XX.x | 828.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Dairy Alternatives | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ingredient Use | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United Kingdom Alternative Protein Market Product Form 2025-2033 (USD Million)
| Product Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ready To Eat | XX.x | XX.x | XX.x | 774.72 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Powdered Ingredients | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Liquid Concentrates | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.